10/21/2025
🌟 Thinking About Switching From Tirzepatide to GLP-3? Here’s What to Expect 🌟
Many of our patients have been hearing about GLP-3 — a next-generation peptide designed to target three key metabolic pathways (GLP-1, GIP, and glucagon) for even more powerful weight-management results.
If you’ve been on Tirzepatide (Mounjaro or Zepbound) and are curious about switching, here’s what you should know:
✅ Different Mechanism, Same Weekly Injection
GLP-3 builds on the same principles as Tirzepatide but adds a third receptor target that may help boost metabolism and energy burn in addition to appetite control.
⏳ You Might Not Feel the Same “Appetite Drop” Right Away
Because your body is already used to GLP-1 and GIP signaling from Tirzepatide, the initial appetite suppression with GLP-3 can feel a bit lighter at first.
💡 What to Expect During the Switch
Appetite control may fluctuate for a few weeks.
Your provider will monitor your weight, appetite, and toleranc.e
Side effects are often similar — mild nausea, fullness, or slower digestion.
Patience is key; this is a reset phase for your metabolism.
❤️ Why Consider GLP-3?
Early studies show impressive weight-loss results (up to 24% at 48 weeks) — even higher than with current GLP-1 therapies — with potential improvements in blood sugar, energy levels, and body composition.
✨ At Dupre Medical Clinic, we guide every patient through the transition safely — tracking progress and supporting you every step of the way.
📅 Ready to talk about whether GLP-3 might be right for you?
Call us at 337-363-5531 to schedule your consultation.
